Publicaciones en colaboración con investigadores/as de Universidad de Navarra (18)

2023

  1. Next generation of selenocyanate and diselenides with upgraded leishmanicidal activity

    Bioorganic Chemistry, Vol. 138

2022

  1. RICORS2040: The need for collaborative research in chronic kidney disease

    Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387

2021

  1. 3,5-Dimethyl-4-isoxazoyl selenocyanate as promising agent for the treatment of Leishmania infantum-infected mice

    Acta Tropica, Vol. 215

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  3. New amides containing selenium as potent leishmanicidal agents targeting trypanothione reductase

    Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 1

  4. New phosphoramidates containing selenium as leishmanicidal agents

    Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 10

2020

  1. Pre-clinical evidences of the antileishmanial effects of diselenides and selenocyanates

    Bioorganic and Medicinal Chemistry Letters, Vol. 30, Núm. 17

2019

  1. Discovery of new organoselenium compounds as antileishmanial agents

    Bioorganic Chemistry, Vol. 86, pp. 339-345

  2. Synthesis and leishmanicidal activity of novel urea, thiourea, and selenourea derivatives of diselenides

    Antimicrobial Agents and Chemotherapy, Vol. 63, Núm. 5

2016

  1. Guideline for dialysate quality of Spanish Society of Nephrology (second edition, 2015)

    Nefrologia, Vol. 36, Núm. 3, pp. e1-e52

  2. Guía de gestión de calidad del líquido de diálisis (LD) (segunda edición, 2015)

    Nefrologia, Vol. 36, Núm. 3, pp. e1-e52

  3. Novel heteroaryl selenocyanates and diselenides as potent antileishmanial agents

    Antimicrobial Agents and Chemotherapy, Vol. 60, Núm. 6, pp. 3802-3812

2014

  1. Novel hybrid selenosulfonamides as potent antileishmanial agents

    European Journal of Medicinal Chemistry, Vol. 74, pp. 116-123

2011

  1. Antileishmanial activity of imidothiocarbamates and imidoselenocarbamates

    Parasitology Research, Vol. 108, Núm. 1, pp. 233-239

  2. Selenocyanates and diselenides: A new class of potent antileishmanial agents

    European Journal of Medicinal Chemistry, Vol. 46, Núm. 8, pp. 3315-3323

2008

  1. Differences and molecular immunohistochemical parameters in the subtypes of infiltrating ductal breast cancer

    American Journal of Clinical Pathology, Vol. 130, Núm. 3, pp. 414-424

  2. Epigenetic inactivation of the Groucho homologue gene TLE1 in hematologic malignancies

    Cancer Research, Vol. 68, Núm. 11, pp. 4116-4122

2005

  1. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer

    Nature Genetics, Vol. 37, Núm. 4, pp. 391-400